scholarly journals IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides for managing COVID-19 severity

2021 ◽  
Author(s):  
Shipra Jain ◽  
Anjali Dhall ◽  
Sumeet Patiyal ◽  
Gajendra P. S. Raghava

AbstractInterleukin 13 (IL-13) is an immunoregulatory cytokine that is primarily released by activated T-helper 2 cells. It induces the pathogenesis of many allergic diseases, such as airway hyperresponsiveness, glycoprotein hypersecretion and goblet cell hyperplasia. IL-13 also inhibits tumor immunosurveillance, which leads to carcinogenesis. In recent studies, elevated IL-13 serum levels have been shown in severe COVID-19 patients. Thus it is important to predict IL-13 inducing peptides or regions in a protein for designing safe protein therapeutics particularly immunotherapeutic. This paper describes a method developed for predicting, designing and scanning IL-13 inducing peptides. The dataset used in this study contain experimentally validated 313 IL-13 inducing peptides and 2908 non-inducing homo-sapiens peptides extracted from the immune epitope database (IEDB). We have extracted 95 key features using SVC-L1 technique from the originally generated 9165 features using Pfeature. Further, these key features were ranked based on their prediction ability, and top 10 features were used for building machine learning prediction models. In this study, we have deployed various machine learning techniques to develop models for predicting IL-13 inducing peptides. These models were trained, test and evaluated using five-fold cross-validation techniques; best model were evaluated on independent dataset. Our best model based on XGBoost achieves a maximum AUC of 0.83 and 0.80 on the training and independent dataset, respectively. Our analysis indicate that certain SARS-COV2 variants are more prone to induce IL-13 in COVID-19 patients. A standalone package as well as a web server named ‘IL-13Pred’ has been developed for predicting IL-13 inducing peptides (https://webs.iiitd.edu.in/raghava/il13pred/).Key PointsInterleukin-13, an immunoregulatory cytokine plays an important role in increasing severity of COVID-19 and other diseases.IL-13Pred is a highly accurate in-silico method developed for predicting the IL-13 inducing peptides/ epitopes.IL-13 inducing peptides are reported in various SARS-CoV2 strains/variants proteins.This method can be used to detect IL-13 inducing peptides in vaccine candidates.User friendly web server and standalone software is freely available for IL-13PredAuthor’s BiographyShipra Jain is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.Anjali Dhall is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.Sumeet Patiyal is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.Gajendra P. S. Raghava is currently working as Professor and Head of Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.

2021 ◽  
Author(s):  
Anjali Dhall ◽  
Sumeet Patiyal ◽  
Gajendra P. S. Raghava

AbstractIn the last two decades, ample of methods have been developed to predict the classical HLA binders in an antigen. In contrast, limited attempts have been made to develop methods for predicting binders for non-classical HLA; due to the scarcity of sufficient experimental data and lack of community interest. Of Note, non-classical HLA plays a crucial immunomodulatory role and regulates various immune responses. Recent studies revealed that non-classical HLA (HLA-E & HLA-G) based immunotherapies have many advantages over classical HLA based-immunotherapy, particularly against COVID-19. In order to facilitate the scientific community, we have developed an artificial intelligence-based method for predicting binders of non-classical HLA alleles (HLA-G and HLA-E). All the models were trained and tested on experimentally validated data obtained from the recent release of IEDB. The machine learning based-models achieved more than 0.98 AUC for HLA-G alleles on validation or independent dataset. Similarly, our models achieved the highest AUC of 0.96 and 0.88 on the validation dataset for HLA-E*01:01, HLA-E*01:03, respectively. We have summarized the models developed in the past for non-classical HLA binders and compared with the models developed in this study. Moreover, we have also predicted the non-classical HLA binders in the spike protein of different variants of virus causing COVID-19 including omicron (B.1.1.529) to facilitate the community. One of the major challenges in the field of immunotherapy is to identify the promiscuous binders or antigenic regions that can bind to a large number of HLA alleles. In order to predict the promiscuous binders for the non-classical HLA alleles, we developed a web server HLAncPred (https://webs.iiitd.edu.in/raghava/hlancpred), and a standalone package.Key PointsNon-classical HLAs play immunomodulatory roles in the immune system.HLA-E restricted T-cell therapy may reduce COVID-19 associated cytokine storm.In silico models developed for predicting binders for HLA-G and HLA-E.Identification of non-classical HLA binders in strains of coronavirusA webserver for predicting promiscuous binders for non-classical HLA allelesAuthor’s BiographyAnjali Dhall is currently working as Ph.D. in Bioinformatics from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.Sumeet Patiyal is currently working as Ph.D. in Bioinformatics from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.Gajendra P. S. Raghava is currently working as Professor and Head of Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.


Synlett ◽  
2020 ◽  
Author(s):  
Shuo-Qing Zhang ◽  
Xin Hong ◽  
Li-Cheng Xu ◽  
Xin Li ◽  
Miao-Jiong Tang ◽  
...  

AbstractDescription of molecular stereostructure is critical for the machine learning prediction of asymmetric catalysis. Herein we report a spherical projection descriptor of molecular stereostructure (SPMS), which allows precise representation of the molecular van der Waals (vdW) surface. The key features of SPMS descriptor are presented using the examples of chiral phosphoric acid, and the machine learning application is demonstrated in Denmark’s dataset of asymmetric thiol addition to N-acylimines. In addition, SPMS descriptor also offers a color-coded diagram that provides straightforward chemical interpretation of the steric environment.


2017 ◽  
Vol 1 (3) ◽  
pp. 257-274 ◽  
Author(s):  
William Jones ◽  
Kaur Alasoo ◽  
Dmytro Fishman ◽  
Leopold Parts

Deep learning is the trendiest tool in a computational biologist's toolbox. This exciting class of methods, based on artificial neural networks, quickly became popular due to its competitive performance in prediction problems. In pioneering early work, applying simple network architectures to abundant data already provided gains over traditional counterparts in functional genomics, image analysis, and medical diagnostics. Now, ideas for constructing and training networks and even off-the-shelf models have been adapted from the rapidly developing machine learning subfield to improve performance in a range of computational biology tasks. Here, we review some of these advances in the last 2 years.


2018 ◽  
pp. 2157-2162
Author(s):  
Cornelia Caragea ◽  
Vasant Honavar

2019 ◽  
Vol 7 (1) ◽  
pp. 82-85
Author(s):  
Geetha Swaminathan

In the 21st Century, the buzzword is often used in all fields is “Innovation". It is no wonder using Innovation in day to the conversation as well as striving for innovation execution at organisations in Information Technology (IT) sectors. When we need to talk about innovation in IT sectors in the fast-moving technology IT organisations, they are in a position in increasing its capability in its innovative product and services. There is a lot of benefits out of business innovations that are being reaped in IT companies; there are apparent disadvantages are also the outcome of them. It is quite common, despite all benefits and drawbacks, they are in apposition to survive in the global market. That becomes a great challenge to all IT organisations. In IT organisations which consist of departments such as Development, Testing, Consulting, Networking, Infrastructure, Process and having common platforms and legacy languages, Apart from that they are in the way of invading new technologies such as Digital, Mobile, IoT, Artificial Intelligence, Machine learning Cloud computing. In all the fields, as mentioned above and area, they need to do innovation to sustain their business. This paper will provide elaborate results on Pros and Cons of Business Innovation in IT Organization.


2021 ◽  
Author(s):  
Aditya Nagori ◽  
Anushtha Kalia ◽  
Arjun Sharma ◽  
Pradeep Singh ◽  
Harsh Bandhey ◽  
...  

Shock is a major killer in the ICU and machine learning based early predictions can potentially save lives. Generalization across age and geographical context is an unaddressed challenge. In this retrospective observational study, we built real-time shock prediction models generalized across age groups and continents. More than 1.5 million patient-hours of novel data from a pediatric ICU in New Delhi and 5 million patient-hours from the adult ICU MIMIC database were used to build models. We achieved model generalization through a novel fractal deep-learning approach and predicted shock up to 12 hours in advance. Our deep learning models showed a receiver operating curve (AUROC) drop from 78% (95%CI, 73-83) on MIMIC data to 66% (95%CI, 54-78) on New Delhi data, outperforming standard machine learning by nearly a 10% gap. Therefore, better representations and deep learning can partly address the generalizability-gap of ICU prediction models trained across geographies. Our data and algorithms are publicly available as a pre-configured docker environment at https://github.com/SAFE-ICU/ShoQPred.


Sign in / Sign up

Export Citation Format

Share Document